Blue Biotechnology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Blue biotechnology is the application of molecular biological methods to marine and freshwater organisms. These organisms are used for purposes like increasing seafood supply and safety, controlling the reproduction of dangerous water-borne organisms, and developing new drugs.

The global market for Blue Biotechnology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Blue Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Blue Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Blue Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Blue Biotechnology include Aker BioMarine, Marinova, New England Biolabs, PML Applications, Sea Run Holdings, PICES, Donald Danforth Plant Science Center, Shell Marine Products and GeoMarine Biotechnologies, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Blue Biotechnology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blue Biotechnology by region & country, by Type, and by Application.

The Blue Biotechnology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blue Biotechnology.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blue Biotechnology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Blue Biotechnology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Blue Biotechnology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Blue Biotechnology Product Introduction
    1.2 Global Blue Biotechnology Market Size Forecast
    1.3 Blue Biotechnology Market Trends & Drivers
        1.3.1 Blue Biotechnology Industry Trends
        1.3.2 Blue Biotechnology Market Drivers & Opportunity
        1.3.3 Blue Biotechnology Market Challenges
        1.3.4 Blue Biotechnology Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Blue Biotechnology Players Revenue Ranking (2023)
    2.2 Global Blue Biotechnology Revenue by Company (2019-2024)
    2.3 Key Companies Blue Biotechnology Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Blue Biotechnology Product Offered
    2.5 Key Companies Time to Begin Mass Production of Blue Biotechnology
    2.6 Blue Biotechnology Market Competitive Analysis
        2.6.1 Blue Biotechnology Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Blue Biotechnology Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blue Biotechnology as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Enzymes
        3.1.2 Pharma Products
        3.1.3 Bulk Chemicals
        3.1.4 Biopolymers
    3.2 Global Blue Biotechnology Sales Value by Type
        3.2.1 Global Blue Biotechnology Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Blue Biotechnology Sales Value, by Type (2019-2030)
        3.2.3 Global Blue Biotechnology Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Bio-Engineering
        4.1.2 Genomics
        4.1.3 Vaccine Development
        4.1.4 Drug Discovery
        4.1.5 Others
    4.2 Global Blue Biotechnology Sales Value by Application
        4.2.1 Global Blue Biotechnology Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Blue Biotechnology Sales Value, by Application (2019-2030)
        4.2.3 Global Blue Biotechnology Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Blue Biotechnology Sales Value by Region
        5.1.1 Global Blue Biotechnology Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Blue Biotechnology Sales Value by Region (2019-2024)
        5.1.3 Global Blue Biotechnology Sales Value by Region (2025-2030)
        5.1.4 Global Blue Biotechnology Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Blue Biotechnology Sales Value, 2019-2030
        5.2.2 North America Blue Biotechnology Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Blue Biotechnology Sales Value, 2019-2030
        5.3.2 Europe Blue Biotechnology Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Blue Biotechnology Sales Value, 2019-2030
        5.4.2 Asia Pacific Blue Biotechnology Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Blue Biotechnology Sales Value, 2019-2030
        5.5.2 South America Blue Biotechnology Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Blue Biotechnology Sales Value, 2019-2030
        5.6.2 Middle East & Africa Blue Biotechnology Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Blue Biotechnology Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Blue Biotechnology Sales Value
    6.3 United States
        6.3.1 United States Blue Biotechnology Sales Value, 2019-2030
        6.3.2 United States Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Blue Biotechnology Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Blue Biotechnology Sales Value, 2019-2030
        6.4.2 Europe Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Blue Biotechnology Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Blue Biotechnology Sales Value, 2019-2030
        6.5.2 China Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Blue Biotechnology Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Blue Biotechnology Sales Value, 2019-2030
        6.6.2 Japan Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Blue Biotechnology Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Blue Biotechnology Sales Value, 2019-2030
        6.7.2 South Korea Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Blue Biotechnology Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Blue Biotechnology Sales Value, 2019-2030
        6.8.2 Southeast Asia Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Blue Biotechnology Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Blue Biotechnology Sales Value, 2019-2030
        6.9.2 India Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Blue Biotechnology Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Aker BioMarine
        7.1.1 Aker BioMarine Profile
        7.1.2 Aker BioMarine Main Business
        7.1.3 Aker BioMarine Blue Biotechnology Products, Services and Solutions
        7.1.4 Aker BioMarine Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.1.5 Aker BioMarine Recent Developments
    7.2 Marinova
        7.2.1 Marinova Profile
        7.2.2 Marinova Main Business
        7.2.3 Marinova Blue Biotechnology Products, Services and Solutions
        7.2.4 Marinova Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.2.5 Marinova Recent Developments
    7.3 New England Biolabs
        7.3.1 New England Biolabs Profile
        7.3.2 New England Biolabs Main Business
        7.3.3 New England Biolabs Blue Biotechnology Products, Services and Solutions
        7.3.4 New England Biolabs Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.3.5 PML Applications Recent Developments
    7.4 PML Applications
        7.4.1 PML Applications Profile
        7.4.2 PML Applications Main Business
        7.4.3 PML Applications Blue Biotechnology Products, Services and Solutions
        7.4.4 PML Applications Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.4.5 PML Applications Recent Developments
    7.5 Sea Run Holdings
        7.5.1 Sea Run Holdings Profile
        7.5.2 Sea Run Holdings Main Business
        7.5.3 Sea Run Holdings Blue Biotechnology Products, Services and Solutions
        7.5.4 Sea Run Holdings Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.5.5 Sea Run Holdings Recent Developments
    7.6 PICES
        7.6.1 PICES Profile
        7.6.2 PICES Main Business
        7.6.3 PICES Blue Biotechnology Products, Services and Solutions
        7.6.4 PICES Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.6.5 PICES Recent Developments
    7.7 Donald Danforth Plant Science Center
        7.7.1 Donald Danforth Plant Science Center Profile
        7.7.2 Donald Danforth Plant Science Center Main Business
        7.7.3 Donald Danforth Plant Science Center Blue Biotechnology Products, Services and Solutions
        7.7.4 Donald Danforth Plant Science Center Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.7.5 Donald Danforth Plant Science Center Recent Developments
    7.8 Shell Marine Products
        7.8.1 Shell Marine Products Profile
        7.8.2 Shell Marine Products Main Business
        7.8.3 Shell Marine Products Blue Biotechnology Products, Services and Solutions
        7.8.4 Shell Marine Products Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.8.5 Shell Marine Products Recent Developments
    7.9 GeoMarine Biotechnologies
        7.9.1 GeoMarine Biotechnologies Profile
        7.9.2 GeoMarine Biotechnologies Main Business
        7.9.3 GeoMarine Biotechnologies Blue Biotechnology Products, Services and Solutions
        7.9.4 GeoMarine Biotechnologies Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.9.5 GeoMarine Biotechnologies Recent Developments
    7.10 GlycoMar
        7.10.1 GlycoMar Profile
        7.10.2 GlycoMar Main Business
        7.10.3 GlycoMar Blue Biotechnology Products, Services and Solutions
        7.10.4 GlycoMar Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.10.5 GlycoMar Recent Developments
    7.11 Cellgen Biologicals
        7.11.1 Cellgen Biologicals Profile
        7.11.2 Cellgen Biologicals Main Business
        7.11.3 Cellgen Biologicals Blue Biotechnology Products, Services and Solutions
        7.11.4 Cellgen Biologicals Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.11.5 Cellgen Biologicals Recent Developments
    7.12 Nurture Aqua Technology
        7.12.1 Nurture Aqua Technology Profile
        7.12.2 Nurture Aqua Technology Main Business
        7.12.3 Nurture Aqua Technology Blue Biotechnology Products, Services and Solutions
        7.12.4 Nurture Aqua Technology Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.12.5 Nurture Aqua Technology Recent Developments
    7.13 Samudra Biopharma
        7.13.1 Samudra Biopharma Profile
        7.13.2 Samudra Biopharma Main Business
        7.13.3 Samudra Biopharma Blue Biotechnology Products, Services and Solutions
        7.13.4 Samudra Biopharma Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.13.5 Samudra Biopharma Recent Developments
    7.14 Sanosil Biotech
        7.14.1 Sanosil Biotech Profile
        7.14.2 Sanosil Biotech Main Business
        7.14.3 Sanosil Biotech Blue Biotechnology Products, Services and Solutions
        7.14.4 Sanosil Biotech Blue Biotechnology Revenue (US$ Million) & (2019-2024)
        7.14.5 Sanosil Biotech Recent Developments

 8 Industry Chain Analysis
    8.1 Blue Biotechnology Industrial Chain
    8.2 Blue Biotechnology Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Blue Biotechnology Sales Model
        8.5.2 Sales Channel
        8.5.3 Blue Biotechnology Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Blue Biotechnology Market Trends
    Table 2. Blue Biotechnology Market Drivers & Opportunity
    Table 3. Blue Biotechnology Market Challenges
    Table 4. Blue Biotechnology Market Restraints
    Table 5. Global Blue Biotechnology Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Blue Biotechnology Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Blue Biotechnology Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Blue Biotechnology Product Type
    Table 9. Key Companies Time to Begin Mass Production of Blue Biotechnology
    Table 10. Global Blue Biotechnology Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blue Biotechnology as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Blue Biotechnology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Blue Biotechnology Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Blue Biotechnology Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Blue Biotechnology Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Blue Biotechnology Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Blue Biotechnology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Blue Biotechnology Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Blue Biotechnology Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Blue Biotechnology Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Blue Biotechnology Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Blue Biotechnology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Blue Biotechnology Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Blue Biotechnology Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Blue Biotechnology Sales Value by Region (2019-2024) & (%)
    Table 27. Global Blue Biotechnology Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Blue Biotechnology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Blue Biotechnology Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Blue Biotechnology Sales Value, (2025-2030) & (US$ Million)
    Table 31. Aker BioMarine Basic Information List
    Table 32. Aker BioMarine Description and Business Overview
    Table 33. Aker BioMarine Blue Biotechnology Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Blue Biotechnology Business of Aker BioMarine (2019-2024)
    Table 35. Aker BioMarine Recent Developments
    Table 36. Marinova Basic Information List
    Table 37. Marinova Description and Business Overview
    Table 38. Marinova Blue Biotechnology Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Blue Biotechnology Business of Marinova (2019-2024)
    Table 40. Marinova Recent Developments
    Table 41. New England Biolabs Basic Information List
    Table 42. New England Biolabs Description and Business Overview
    Table 43. New England Biolabs Blue Biotechnology Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Blue Biotechnology Business of New England Biolabs (2019-2024)
    Table 45. New England Biolabs Recent Developments
    Table 46. PML Applications Basic Information List
    Table 47. PML Applications Description and Business Overview
    Table 48. PML Applications Blue Biotechnology Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Blue Biotechnology Business of PML Applications (2019-2024)
    Table 50. PML Applications Recent Developments
    Table 51. Sea Run Holdings Basic Information List
    Table 52. Sea Run Holdings Description and Business Overview
    Table 53. Sea Run Holdings Blue Biotechnology Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Blue Biotechnology Business of Sea Run Holdings (2019-2024)
    Table 55. Sea Run Holdings Recent Developments
    Table 56. PICES Basic Information List
    Table 57. PICES Description and Business Overview
    Table 58. PICES Blue Biotechnology Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Blue Biotechnology Business of PICES (2019-2024)
    Table 60. PICES Recent Developments
    Table 61. Donald Danforth Plant Science Center Basic Information List
    Table 62. Donald Danforth Plant Science Center Description and Business Overview
    Table 63. Donald Danforth Plant Science Center Blue Biotechnology Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Blue Biotechnology Business of Donald Danforth Plant Science Center (2019-2024)
    Table 65. Donald Danforth Plant Science Center Recent Developments
    Table 66. Shell Marine Products Basic Information List
    Table 67. Shell Marine Products Description and Business Overview
    Table 68. Shell Marine Products Blue Biotechnology Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Blue Biotechnology Business of Shell Marine Products (2019-2024)
    Table 70. Shell Marine Products Recent Developments
    Table 71. GeoMarine Biotechnologies Basic Information List
    Table 72. GeoMarine Biotechnologies Description and Business Overview
    Table 73. GeoMarine Biotechnologies Blue Biotechnology Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Blue Biotechnology Business of GeoMarine Biotechnologies (2019-2024)
    Table 75. GeoMarine Biotechnologies Recent Developments
    Table 76. GlycoMar Basic Information List
    Table 77. GlycoMar Description and Business Overview
    Table 78. GlycoMar Blue Biotechnology Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Blue Biotechnology Business of GlycoMar (2019-2024)
    Table 80. GlycoMar Recent Developments
    Table 81. Cellgen Biologicals Basic Information List
    Table 82. Cellgen Biologicals Description and Business Overview
    Table 83. Cellgen Biologicals Blue Biotechnology Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Blue Biotechnology Business of Cellgen Biologicals (2019-2024)
    Table 85. Cellgen Biologicals Recent Developments
    Table 86. Nurture Aqua Technology Basic Information List
    Table 87. Nurture Aqua Technology Description and Business Overview
    Table 88. Nurture Aqua Technology Blue Biotechnology Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Blue Biotechnology Business of Nurture Aqua Technology (2019-2024)
    Table 90. Nurture Aqua Technology Recent Developments
    Table 91. Samudra Biopharma Basic Information List
    Table 92. Samudra Biopharma Description and Business Overview
    Table 93. Samudra Biopharma Blue Biotechnology Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Blue Biotechnology Business of Samudra Biopharma (2019-2024)
    Table 95. Samudra Biopharma Recent Developments
    Table 96. Sanosil Biotech Basic Information List
    Table 97. Sanosil Biotech Description and Business Overview
    Table 98. Sanosil Biotech Blue Biotechnology Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Blue Biotechnology Business of Sanosil Biotech (2019-2024)
    Table 100. Sanosil Biotech Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Blue Biotechnology Downstream Customers
    Table 104. Blue Biotechnology Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Blue Biotechnology Product Picture
    Figure 2. Global Blue Biotechnology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Blue Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 4. Blue Biotechnology Report Years Considered
    Figure 5. Global Blue Biotechnology Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Blue Biotechnology Revenue in 2023
    Figure 7. Blue Biotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Enzymes Picture
    Figure 9. Pharma Products Picture
    Figure 10. Bulk Chemicals Picture
    Figure 11. Biopolymers Picture
    Figure 12. Global Blue Biotechnology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Blue Biotechnology Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Bio-Engineering
    Figure 15. Product Picture of Genomics
    Figure 16. Product Picture of Vaccine Development
    Figure 17. Product Picture of Drug Discovery
    Figure 18. Product Picture of Others
    Figure 19. Global Blue Biotechnology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Blue Biotechnology Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Blue Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Blue Biotechnology Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Blue Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Blue Biotechnology Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Blue Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Blue Biotechnology Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Blue Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Blue Biotechnology Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Blue Biotechnology Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Blue Biotechnology Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Blue Biotechnology Sales Value (%), (2019-2030)
    Figure 32. United States Blue Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Blue Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Blue Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Blue Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Blue Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Blue Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Blue Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Blue Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Blue Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Blue Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Blue Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Blue Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Blue Biotechnology Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Blue Biotechnology Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Blue Biotechnology Sales Value by Application (%), 2023 VS 2030
    Figure 53. Blue Biotechnology Industrial Chain
    Figure 54. Blue Biotechnology Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation

Blue biotechnology is the application of molecular biological methods to marine and freshwater organisms. These organisms are used for purposes like increasing seafood supply and safety, controlling the reproduction of dangerous water-borne organisms, and developing new drugs.

The global market for Blue Biotechnology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Blue Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Blue Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Blue Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Blue Biotechnology include Aker BioMarine, Marinova, New England Biolabs, PML Applications, Sea Run Holdings, PICES, Donald Danforth Plant Science Center, Shell Marine Products and GeoMarine Biotechnologies, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Blue Biotechnology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blue Biotechnology by region & country, by Type, and by Application.

The Blue Biotechnology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blue Biotechnology.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blue Biotechnology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Blue Biotechnology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Blue Biotechnology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.